An indirect treatment comparison of efficacy and health-related quality of life following treatment with idecabtagene vicleucel versus belantamab mafodotin in triple-class exposed relapsed/refractory patients with multiple myeloma
Beteiligte Einrichtungen
Bibliografische Daten
Originalsprache | Englisch |
---|---|
ISSN | 1042-8194 |
DOIs | |
Status | Veröffentlicht - 2023 |
PubMed | 37497883 |
---|